TABLE 1 MITOCHONDRIAL MYOPATHY DIAGNOSIS & TREATMENT MARKET: PIPELINE ANALYSIS 23
TABLE 2 GLOBAL MITOCHONDRIAL MYOPATHY DIAGNOSIS & TREATMENT MARKET, BY TYPE, 2014 -2020 (USD Million) 34
TABLE 4 GLOBAL MITOCHONDRIAL MYOPATHY DIAGNOSIS & TREATMENT MARKET, BY DIAGNOSTIC TEST, 2014-2020 (USD Million) 38
TABLE 6 GLOBAL MITOCHONDRIAL MYOPATHY DIAGNOSIS & TREATMENT MARKET, BY THERAPY, 2014-2020 (USD Million) 40
TABLE 8 GLOBAL MITOCHONDRIAL MYOPATHY DIAGNOSIS & TREATMENT MARKET, BY REGION, 2014-2020 (USD Million) 43
TABLE 10 AMERICAS MITOCHONDRIAL MYOPATHIES DIAGNOSIS & TREATMENT MARKET, BY REGION, 2014-2020 (USD Million) 44
TABLE 12 EUROPE MITOCHONDRIAL MYOPATHIES DIAGNOSIS & TREATMENT MARKET, BY REGION, 2014-2020 (USD Million) 45
TABLE 14 ASIA PACIFIC MITOCHONDRIAL MYOPATHIES DIAGNOSIS & TREATMENT MARKET, BY REGION, 2014-2020 (USD Million) 47
TABLE 16 MIDDLE EAST & AFRICA MITOCHONDRIAL MYOPATHIES DIAGNOSIS & TREATMENT MARKET, BY REGION, 2014-2020 (USD Million) 48

LIST OF FIGURE

FIGURE 1 GLOBAL MITOCHONDRIAL MYOPATHY DIAGNOSIS & TREATMENT MARKET: MARKET STRUCTURE 11
FIGURE 2 RESEARCH PROCESS OF MRFR 12
FIGURE 3 FORECAST INDICATORS 14
FIGURE 4 PORTERS FIVE FORCES MODEL 19
FIGURE 5 GLOBAL MITOCHONDRIAL MYOPATHY DIAGNOSIS & TREATMENT MARKET BY TYPE, 2016 & 2020 (USD Million) 34
FIGURE 6 GLOBAL MITOCHONDRIAL MYOPATHY DIAGNOSIS & TREATMENT MARKET BY DIAGNOSTIC TEST, 2016 & 2020 (USD Million) 37
FIGURE 7 GLOBAL MITOCHONDRIAL MYOPATHY DIAGNOSIS & TREATMENT MARKET BY THERAPY, 2016 & 2020 (USD Million) 40
FIGURE 8 GLOBAL MITOCHONDRIAL MYOPATHY DIAGNOSIS & TREATMENT MARKET BY REGION, 2016 & 2020 (USD Million) 43
FIGURE 9 ABBVIE: RECENT FINANCIAL 49
FIGURE 10 ABBVIE: GEOGRAPHIC MIX, 2016 (%) 50
FIGURE 11 NEUROVIVE PHARMACEUTICAL AB: RECENT FINANCIALS 56
FIGURE 12 REATA PHARMACEUTICALS: RECENT FINANCIALS 58
FIGURE 13 REATA PHARMACEUTICALS: R&D EXPENSES, 2016 (%) 59